A controversial weight-loss medication GLP-1 (the main ingredient of Ozempic) raises huge questions on the long-term effects and who should be taking it. Here, 3 industry experts weigh in on its implications and why an informed approach is key. GLP-1 (glucagon-like peptide 1) medications are on the rise and have controversially garnered attention by those seeking rapid and dramatic weight loss.
Developed to manage Type 2 diabetes, it lowers blood sugar levels and reduces potential heart attack risks in adults. As a weight loss remedy, the medication works by mimicking the action of GLP-1, a naturally occurring hormone, to effectively suppress the appetite and delay digestion process. “One of the ways that GLP-1 receptor agonists work to reduce weight is by slowing gastric emptying which may increase the risk of vomiting and aspirating food during anaesthesia.
Severe gastric problems can also occur with recent studies that have found an increase in risk for pancreatitis, intestinal obstruction and gastroparesis when taking GLP-1 receptor agonists,” says Dr Ruhil Badiani, Family Physician at Cornerstone Clinic. With its widespread adoption, it’s important to arm yourself with guided knowledge of its side effects, particularly for women. Dr.
Mahadevan, Ayurvedic Physician at Wellth says, “Women who engage in crash diets frequently have amenorrhoea, which is the absence of periods for more than three months as a result of severe weight loss and starvation.” “One of th.
